Buchumschlag

A subtype‐selective photoswitchable agonist for precise manipulation of GABAA receptors

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Simon Miguel M. Lopez, Jay‐Ron Lee, Wan‐Chen Lin
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Spatiotemporal control in biomedicine: photoswitchable peptides and foldamers
von: Eszter Erdei, et al.
Veröffentlicht: (2025)

Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors
von: Jessica L. Meades, et al.
Veröffentlicht: (2025)

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease
von: Weicong Zhang, et al.
Veröffentlicht: (2024)

Efficacy and safety of a selective partial agonist for nociception/orphanin‐FQ peptide (NOP) receptors in patients with insomnia disorder
von: Garth T. Whiteside, et al.
Veröffentlicht: (2025)

Inhibition of TRPM8 function by prostacyclin receptor agonists requires coupling to Gq/11 proteins
von: Cosmin Trif, et al.
Veröffentlicht: (2024)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants
von: Rosa Luo, et al.
Veröffentlicht: (2025)

An agonist of the adenosine A2A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway
von: Qiuqin Sun, et al.
Veröffentlicht: (2024)

Role for the liver X receptor agonist 22‐ketositosterol in preventing disease progression in an Alzheimer's disease mouse model
von: Nikita Martens, et al.
Veröffentlicht: (2025)

Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
von: Martin E. Cooper, et al.
Veröffentlicht: (2024)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
von: H. Ongun Onaran, et al.
Veröffentlicht: (2024)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
von: Takayuki Suzuki, et al.
Veröffentlicht: (2026)

The pancreatic signal of GLP‐1 receptor agonists: A biliary phenomenon rather than direct toxicity
von: Andro Koren, et al.
Veröffentlicht: (2026)

GLP‐1 receptor agonists and reduced dementia risk: Real‐world evidence stacks up
von: Yun Wah Lam, et al.
Veröffentlicht: (2026)

Feedback control of excitability and high K + induced epileptiform bursts in male rat hippocampal slices with a photocaged adenosine A 1 receptor agonist
von: Erine Craey, et al.
Veröffentlicht: (2026)

Structural bases for stoichiometry‐selective calcium potentiation of a neuronal nicotinic receptor
von: Simone Mazzaferro, et al.
Veröffentlicht: (2024)

Systemic EP4 receptor agonist and Arginase‐1 therapy in a murine model of chronic asthma and influenza virus‐induced asthma exacerbation
von: Tim Lange, et al.
Veröffentlicht: (2025)

ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
von: Omar Soler‐Cedeño, et al.
Veröffentlicht: (2025)

The β 2 ‐adrenoceptor agonist formoterol attenuates hallmarks of adrenal Cushing's syndrome
von: Kristan H. Cleveland, et al.
Veröffentlicht: (2026)

A comment on the interpretation of ligand binding experiments for agonists
von: James P. Higham
Veröffentlicht: (2025)

Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model
von: Rolien Bosch, et al.
Veröffentlicht: (2024)

The potential for biased signalling in the P2Y receptor family of GPCRs
von: Claudia M. Sisk, et al.
Veröffentlicht: (2025)

Biased agonists of GPR84 and insights into biological control
von: Vincent B. Luscombe, et al.
Veröffentlicht: (2024)

Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor
von: Zoe Tasma, et al.
Veröffentlicht: (2024)

Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells
von: Lin Lin, et al.
Veröffentlicht: (2025)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
von: Marta Lopez‐Balastegui, et al.
Veröffentlicht: (2024)

Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes
von: Takatoshi Sakata, et al.
Veröffentlicht: (2025)

A novel selective stabilizer of the ryanodine receptor 2 prevents stress‐induced ventricular arrhythmias without impairing cardiac function
von: Nagomi Kurebayashi, et al.
Veröffentlicht: (2026)

The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System
von: Jianxing Zhou, et al.
Veröffentlicht: (2024)

Paraoxonase‐2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non‐alcoholic steatohepatitis
von: Gu‐Choul Shin, et al.
Veröffentlicht: (2024)

Pharmacological treatment with a GABA(A) receptor modulator and a selective serotonin reuptake inhibitor as a mitigation strategy against aircraft noise‐induced cardiovascular and neuronal damage
von: Ivana Kuntić, et al.
Veröffentlicht: (2026)

Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
von: Qingxiang Lin, et al.
Veröffentlicht: (2024)

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
von: Zoë Vander Elst, et al.
Veröffentlicht: (2026)

The opioid partial agonist PPL‐138 reduces alcohol self‐administration in rats susceptible to post‐traumatic stress disorder
von: Andrea Cippitelli, et al.
Veröffentlicht: (2025)

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases
von: Jiuguo Lin, et al.
Veröffentlicht: (2024)

P2Y14 receptor activation of platelets induces Ca2+ mobilization and Rho‐GTPase‐dependent motility that requires an interaction with P2Y1 receptors
von: Md Monir Hossain, et al.
Veröffentlicht: (2025)

Inhibition of sphingosine‐1‐phosphate receptor‐2 attenuates chronic gastritis via blocking nuclear translocation of S1P 2 receptors in epithelial cells
von: Ke‐Qin Li, et al.
Veröffentlicht: (2025)

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases
von: Bruno Poirier, et al.
Veröffentlicht: (2024)

Opioid receptors in cardiovascular function
von: Venkatesh Katari, et al.
Veröffentlicht: (2025)

Network‐based precision medicine and systems pharmacology
von: Arvind K. Pandey, et al.
Veröffentlicht: (2025)

A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye
von: Yiqin Dai, et al.
Veröffentlicht: (2024)